Introduction
Bacillus cereus and Salmonella typhimurium are zoonotic and foodborne pathogens that infect a wide variety of animal species and human. These pathogens can cause food poisoning and diarrhea; The elderly individuals, pregnant women and immunocompromised patients are at greater risk. The use of antibiotics is the most common method to harness bacteria but thier overuse has resulted in the advent of antibiotic-resistant strains which has retarded the disease treatment. In recent years, researchers have identified the some novel antibacterial compounds to inhibit the drug-resistant strains such as B. cereus and S. typhimurium. 1, 2 Thiazoles have a crucial role in active biological compounds. For instance, the thiazole ring exists in vitamin B1 which is the important coenzyme of the carboxylase enzyme. Some of the thiazole derivatives are applicable as drug in treatment of cancer, blood cholesterol, blood pressure and HIV virus infection. 3 Also, antioxidant and anti-inflammatory activities and inhibitory effects aginst parasites such as Anopheles mosquito or Trypanosoma and fungi such as Candida albicans have been observed with these compounds. [4] [5] [6] [7] [8] Scientists have substantiated the in vitro potency of thiazole derivatives to inhibit the bacterial pathogens like Staphylococcus aureus, Escherichia coli, Staphylococcus epidermidis, Streptococcus pyogenes, Pseudomonas fluorescens and Streptococcus faecalis. Many researchers have implied to the inhibitory potency of thiazole derivatives against bacteria by measuring the growth inhibition zone diameter or MIC or both and we can briefly mention some of the following works; Cheng and colleagues in 2013 showed the in vitro potency of thiazole derivatives to inhibit E. coli, S. aureus and B. subtilis bacteria by measuring MIC. 10 Shah and colleagues in 2012 asserted
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A B S T R A C T
Background: Bacillus cereus and Salmonella typhimurium are important human pathogenic bacteria. The spread of strains of drug-resistant these pathogens has encouraged researchers to identify and use novel antibacterial compounds. In this research project, we studied antibacterial effects of some newly synthesized thiazole, imidazolidine and tetrahydropyrimidine derivatives against B. cereus and S. typhimurium. Methods: 2-(E)-Cyano(thiazolidin-2-ylidene)thiazoles 1-4 and (imidazolidin or tetrahydropyrimidin-2-ylidene)malononitriles 5-11 were synthesized. Then, the disk diffusion and broth microdilution methods were applied to evaluate antibacterial effects. Results were recorded as the minimum inhibitory concentrations (MICs) and the growth inhibition zone diameters.
Results:
The in vitro assessment of antibacterial effects showed that only thiazole derivative 4 had considerable inhibitory effects against B. cereus and S. Typhimurium, whereas the others didn't have so. The inhibitory effects of thiazole derivative 4 against B. cereus and S. typhimurium were proven according to the MICs 125 and 500 µg/mL and the growth inhibition zone diameters 19.2±0.1 and 8.4±0.2 mm, respectively.
Conclusion:
The antibacterial effects of thiazole, imidazolidine and tetrahydropyrimidine derivatives were different, these effects were observed only in thiazole derivative 4. It could be due to the presence of 4-thiazolone ring in derivative 4, witch could reinforce these effects. After confirming that compound 4 is bactericidal against B. cereus and S. typhimurium, further studies can be accomplished on the determination of the cytotoxic and therapeutic effects of this compound in laboratory animals. 22 The broad spectrum of biological activities of thiazole, imidazolidine and tetrahydropyrimidine derivatives has encouraged researchers to develope new synthetic methods. Antibacterial evaluation was one of the first examinations performed after synthesizing these compounds. In this study, we have evaluated the antibacterial effects of novel thiazole, imidazolidine and tetrahydropyrimidine deravetives, which have recently been synthesized in Iran, against B. cereus and S. typhimurium.
A r t i c l e I n f o
Material and Methods
Synthesis of compounds
Thiazole derivatives 1-4, imidazolidine and tetrahydropyrimidine derivatives 5-11 were prepared according to the literature procedures [3] and [23]. 3, 23 The chemical structure of compounds was confirmed by elemental analysis, 1 HNMR, 13 CNMR and IR spectrometry, which have been presented in the Table1. C for 24 h. Henceforth, under sterile conditions for MHA medium and in logarithmic growth phase, the concentration of 10 6 CFU/mL was obtained using spectrophotometer. Each bacterium was assigned as a stock solution. 24 All of the synthesized derivatives were resolved in DMSO by the concentration of 8000 µg/mL.
Determination of the minimum inhibitory concentration (MIC)
The MIC test was performed using broth microdilution method in a sterile 96-well plate according to the CLSI guideline. Average results of three performed tests were calculated. First, 100 µL of Mueller-Hinton broth (MHB) medium (Merck ® , Germany) was added to each well. Then, 100 µL of thiazole, imidazolidine and tetrahydropyrimidine derivatives (in control groups, 100 µL of penicillin or gentamicin antibiotics by the concentration of 512 µg/mL) (Sigma ® ) were added to the first well and then, 100 µL of this mixture was embedded into the second well. Similarly, dilution procedure was done in other wells. 10 µL of bacterial suspension was also added to each well. For negative control, 100 µL of MHB, 100 µL of DMSO and 10 µL of bacterial suspension were added to the last well in each row. The result was recorded after 24 h incubation in 37 o C. The turbidity and lucidity in each well indicated growth or lack of growth for bacteria, respectively. The last well witch didn't show any turbidity, was reported as MIC.
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Determination of the growth inhibition zone diameter First, the superficial bacterial culture was accomplished in MHA medium with a swab impregnated to bacterial suspension. Then, 15 µL of obtained MIC for derivatives and antibiotics (15 µL of DMSO for negative control) was shed on blank sterile disks and incubated for 24 h at 37 o C. Finally, the growth inhibition zone diameter was measured with coulisse. 24 
Data analysis
All experiments were repeated independently three times. The results of the growth inhibition zone diameter have been rendered as average ± standard deviation. Data were analyzed statistically by ANOVA and Tukey's tests at a significance level of PVaule<0.05 using the SPSS statistical software (version 22).
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Results and Discussion
The results indicated that imidazolidine and tetrahydropyrimidine compounds 5-11 and thiazole derivatives 1-3 didn't have inhibitory effects against B. cereus and S. typhimurium bacteria, only the inhibitory effects of thiazole derivative 4 were recorded against these bacteria with the growth inhibition zone diameters = 19.2±0.1, 8.4±0.2 mm and MICs = 125, 500 µg/mL, respectively. In the antibiogram test, the most susceptibility was measured for gentamicin with MIC = 1 µg/mL against S. typhimurium. The results confirmed that DMSO as solvent didn't show inhibitory effects against B. cereus and S. typhimurium (Tables 2  and 3 ). 25 This research confirmed that tetrahydropyrimidine derivatives didn't have broad-spectrum activity against these different types of bacteria. Also, three derivatives of imidazolidine didn't have inhibitory effects against B. cereus and S. typhimurium, but previously some Pharmaceutical Sciences, March 2016, 22, 54-59 | 57 Ghasemi et al. imidazolidine derivatives had shown the ability to inhibit bacteria like Staphylococcus aureus and Escherichia coli, these inhibitory effects are due to substituents such as chlorine atom. 26 1-Methyl-4-nitro-1H-imidazole is a heterocyclic compound known as antibacterial agent for a long time due to its broad spectrum against gram positive and gram negative bacteria and other organisms, experiments asserted the capability of this substance to inhibit or damage Micrococcus luteus, Staphylococcus aureus and Pseudomonas aeruginosa by producing many different kinds of free radicals, the advantage which isn't observed in derivatives 8-10. 27 The only inhibitory effects observed in this research were related to thiazole derivative 4 and no inhibitory effect was seen for analogues 1-3. It can be due to difference in the structure of derivatives. Thiazole derivative 4 consists of a 4-thiazolone ring which has been found to possess strong antimicrobial activities against a wide variety of bacteria. 28, 29 We could prove the potent effects of this compound against E. Coli, S. typhimurium, B. cereus and L. monocytogenes. 9 Liaras and colleagues have shown the inhibitory effects of thiazole-based chalcones against B. cereus and S. typhimurium with MIC = 22.93-38.75 µg/mL. Comparison of these compounds with derivative 4 shows that thiazole nucleus and the carbonyl group are present in both systems, nevertheless, the inhibitory potency of these derivatives is more than derivative 4 that may be due to the existence of chlorine atoms as mono or dichlorophenyl substituent (Figure 1 ). The studies on the antibacterial effects of thiazoles have suggested that these derivatives can inhibit the activities of many enzymes like DNA gyrase B (quinolone antibiotics inhibit DNA gyrase A) or genes such as fabH (which has a vital role in regulation of fatty acid metabolism in bacteria).
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Conclusion
It can be concluded that the derivatives containing 4-thiazolone ring could have inhibitory effects against bacteria. Synthesis of new heterocyclic compounds containing this structure, study of their antibacterial activities against various bacteria especially resistant strains and toxicity effects of synthesized deravetives on laboratory animals are suggested for next researches.
